ICMR To Study How Long Vaccines Will Give Protection

New Delhi : India’s top health research body is all set to study how long Covid-19 vaccine will protect those who are vaccinated and from transmitting the virus to others. The National Institute of Research in TB under the Indian Council of Medical Research (ICMR) has started reviewing a cohort that has received the vaccine to understand the effectiveness of the vaccine.

“Right now it’s slightly premature to answer the question on effectiveness but we are working on it,” Balram Bhargava, DG, Indian Council of Medical Research, told ET. Taking a cue from how the antibody persists post vaccination, the researchers are looking at the data to see the antibody response, protection of antibodies etc. The participants will be followed up for a longer period of time,” said a government official.

Doctors say that many people are hesitant to get Covid-19 vaccine as they wait to learn how long people don’t pass Covid19 if they have been vaccinated.

“We have patients who want to know the effectiveness of the vaccine even as there is evidence that suggests that people who are vaccinated are less likely to have symptomatic infection and less likely transmit. But they are waiting as there is no India specific study so far that gives more confidence to people,” said a senior doctor in a government hospital, requesting anonymity.

  • Related Posts

    • Pharma
    • July 16, 2025
    • 316 views
    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

    • Pharma
    • July 16, 2025
    • 104 views
    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

    The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

    Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

    Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates